Company Analysis

Longeveron Inc. (LGVN)

Nasdaq: LGVN · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 2017
Grade4.2
◀ Past 5.7● Present 2.3▶ Future 4.9
2 est.

Filings

285 filings since 2017 beside 249 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed May 20, 2026.

Filings a yearinsider forms included
169163941048589
20182020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 16 times in the last 36 months, the newest Nov 5, 2026.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Mar 25, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 14, 2025.SEC letters: 21 in the last 36 months, the newest Apr 15, 2026.
Insider forms 249

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K item 5.02 Officer or director change · Current report Nov 1, 2026
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 26, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 14, 2026 8-K item 5.02 Officer or director change · Current report Oct 7, 2026
Sep 23, 2026 8-K items 8.01, 9.01 Other event · Current report Sep 16, 2026
Sep 14, 2026 8-K item 8.01 Other event · Current report Sep 11, 2026
Sep 10, 2026 SCHEDULE 13G Large holder notice
Aug 24, 2026 8-K items 5.03, 7.01, 9.01 Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Aug 20, 2026
Aug 19, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Aug 17, 2026
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 SCHEDULE 13G Large holder notice
Jul 29, 2026 8-K item 8.01 Other event · Current report Jul 24, 2026
Jul 14, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Jul 8, 2026
Jul 10, 2026 S-8 Employee stock plan registration
Jul 8, 2026 8-K item 5.02 Officer or director change · Current report
Jul 6, 2026 8-K items 5.02, 5.03, 5.07, 9.01 Officer or director change; Charter, bylaw or fiscal-year change; Shareholder vote · Current report Jun 30, 2026
Jun 5, 2026 8-K item 5.02 Officer or director change · Current report Jun 1, 2026
May 20, 2026 ARS Annual report to shareholders Dec 31, 2025
May 20, 2026 DEFA14A Extra proxy material
May 20, 2026 DEF 14A Proxy statement Jul 1, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 13, 2026 8-K items 2.02, 9.01 Results released · Current report
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 8, 2026 8-K items 8.01, 9.01 Other event · Current report
May 5, 2026 PRE 14A Preliminary proxy statement
Apr 17, 2026 EFFECT Registration effective
Apr 17, 2026 424B3 Shelf offering
Apr 15, 2026 CORRESP Reply to the SEC
Apr 14, 2026 UPLOAD SEC comment letter
Apr 10, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Mar 25, 2026
Apr 10, 2026 S-1 Listing registration
Mar 25, 2026 D Private placement notice
Mar 25, 2026 8-K item 3.01 Listing warning from its exchange · Current report Mar 24, 2026
Mar 24, 2026 8-K item 8.01 Other event · Current report Mar 23, 2026
Mar 17, 2026 10-K Annual report Dec 31, 2025
Mar 12, 2026 8-K items 1.01, 3.02, 5.03, 8.01, 9.01 Major agreement signed; Shares sold without registration; Charter, bylaw or fiscal-year change; Other event · Current report Mar 10, 2026
40 of 285 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton LGVN · research, not advice